• Nicolas Kluger, Christiane Bruel, and Alain Beauvois.
• Consultation "tatouages", service de dermatologie, hôpital Bichat - Claude-Bernard, Assistance publique-Hôpitaux de Paris, 46, rue Henri-Huchard, 75877 Paris cedex 18, France; Departments of dermatology, allergology and venereology, university of Helsinki and Helsinki university central hospital, 00029 Hus, Finland. Electronic address: nicolas.kluger@hus.fi.
• Presse Med. 2020 Dec 1; 49 (4): 104058.

AbstractSince 2004, tattooing products have been recognized as such by French law. A tattooist must declare his activity to the ARS (French regional health agency). A tattooist is legally compelled to undergo training sessions on occupational safety and hygienic requirements and to deliver his certificate to the ARS. A tattooist commits himself to preliminarily informing his customers of the risks they possibly incur and of the precautions to be taken. He also commits himself to complying with general rules and regulations and with good practices of hygiene and safety; lastly, he signs an agreement pertaining to waste disposal (DASRI). Contrary to pharmaceutical products, tattooing products are not subject to authorization prior to their commercialization. Any adverse effect after tattooing must be the subject of a declaration addressed to the ANSM (French health products safety agency) by the customer, the tattooist or a health professional.Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

16 keywords...

hide…